Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Fibroblast growth factor-21 (FGF-21) is a potent metabolic regulator, which in animal models has been shown to improve glucose metabolism and insulin sensitivity. Recently, FGF-21 was shown to be expressed and secreted from murine muscle cells in response to insulin stimulation. RESEARCH DESIGN AND METHODS: We studied muscular FGF-21 expression and plasma FGF-21 after acute insulin stimulation in young healthy men during a hyperinsulinemic- euglycemic clamp. Furthermore, we investigated systemic levels and muscle FGF-21 expression in humans with or without insulin resistance and chronic elevated insulin. RESULTS: FGF-21 was barely detectable in young healthy men before insulin infusion. After 3 or 4 h of insulin infusion during a hyperinsulinemic-euglycemic clamp, muscular FGF-21 expression increased significantly. Plasma FGF-21 followed the same pattern. In individuals with chronic elevated insulin, muscular FGF-21 expression was associated with hyperinsulinemia in men but not in women. In plasma, hyperinsulinemia and fasting glucose were positively associated with plasma FGF-21 while plasma FGF-21 correlated negatively with HDL cholesterol. No associations between muscle and plasma FGF-21 were found in the individuals with chronic hyperinsulinemia. CONCLUSIONS: FGF-21 is expressed in human skeletal muscle in response to insulin stimulation, suggesting that FGF-21 is an insulin-regulated myokine. In support, we found an association between chronic hyperinsulinemia and levels of FGF-21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibroblast growth factor-21 is regulated by insulin285 through the PI3K/Akt1 signaling pathway.286”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [285]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hojman et al. found that FGF21 is expressed in both plasma and SkM after insulin stimulation in humans, and thus classified FGF21 as an insulin regulatory myokine (Hojman et al., 2009).”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Hojman et al., 2009
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388 · cited 1×
“The main example is IL-6, which is released systemically in response to exercise and modulates metabolic functions in adipose tissue (13).”
BackgroundSelf-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495 · cited 2×
“Mechanistic animal studies focusing on the role of FGF-21 during fasting conditions have shown that FGF-21 is a downstream mediator of peroxisome proliferator– activated receptor- (PPAR- ) (6,7), and PPAR- –induced FGF-21 release leads to 1) stimulation of lipolysis in adipose tissue for the release of fatty acids, 2)…”
BackgroundFibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908 · cited 3×
“Previous studies have shown that plasma FGF-21 correlated significantly with FGF-21 expression in adipose tissue, suggesting that the adipose tissue might be the primary source of plasma FGF-21 in humans (10).”
BackgroundResultThe metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Gälman, C., Lundåsen, T., Kharitonenkov, A., Bina, H. A., Eriksson, M., Hafström, I., Dahlin, M., Åmark, P., Angelin, B., & Rudling, M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.014 · Cited by 512
FGF21 is an Akt‐regulated myokine
Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., & Walsh, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.021 · Cited by 415 · cited 2×
“(14), which found that insulin induced FGF-21 expression in murine muscle cells.”
BackgroundPPARα is a key regulator of hepatic FGF21
Lundåsen, T., Hunt, M. C., Nilsson, L.-M., Sanyal, S., Angelin, B., Alexson, S. E. H., & Rudling, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.068 · Cited by 383
Cited by
Items 101–200 of 211
Fgf21-Dubosiella axis mediates the protective effects of exercise against NAFLD development
Ye, X., Sun, P., Lao, S., Wen, M., Zheng, R., Lin, Y., Gan, L., Fan, X., Wang, P., Li, Z., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122231 · Cited by 46
Torre-Villalvazo, I., Alemán, G., Valle‐Rios, R., & Noriega, L. G. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.06.006 · Cited by 46
Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
Kang, Y. E., Kim, J. T., Lim, M. A., Oh, C., Liu, L., Jung, S., Won, H.-R., Lee, K.-M., Chang, J. W., Yi, H., et al. (2019) · Cancers · doi:10.3390/cancers11081154 · Cited by 46
Li, H., Sun, H., Qian, B., Feng, W. H., Carney, D., Miller, J. P., Hogan, M. V., & Wang, L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3932 · Cited by 46
Acute effect of exercise intensity on circulating FGF-21, FSTL-1, cathepsin B, and BDNF in young men
Ji, M., Cho, C., & Lee, S. (2023) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2023.11.002 · Cited by 41
Sommakia, S., Almaw, N. H., Lee, S. H., Ramadurai, D. K. A., Taleb, I., Kyriakopoulos, C. P., Stubben, C., Jing, L., Campbell, R. A., Alharethi, R. A., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008910 · Cited by 41
FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity
Minami, S., Sakai, S., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Yonishi, H., Nakamura, J., Maeda, S., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2259282 · Cited by 39
Leptin as a Potential Regulator of FGF21
Asrih, M., Veyrat‐Durebex, C., Poher, A.-L., Lyautey, J., Rohner‐Jeanrenaud, F., & Jornayvaz, F. R. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443070 · Cited by 39
Novel Mediators of Adipose Tissue and Muscle Crosstalk
Indrakusuma, I., Sell, H., & Eckel, J. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0174-7 · Cited by 38
KOTULÁK, T., DRÁPALOVÁ, J., KOPECKÝ, P., LACINOVÁ, Z., KRAMÁŘ, P., ŘÍHA, H., NETUKA, I., MALÝ, J., HOUSA, D., BLÁHA, J., et al. (2011) · Physiological Research · doi:10.33549/physiolres.932134 · Cited by 35
FGF21 as a Therapeutic Reagent
Zhao, Y., Dunbar, J. D., & Kharitonenkov, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_14 · Cited by 37
Lindegaard, B., Hvid, T., Grøndahl, T. S., Frøsig, C., Gerstoft, J., Højman, P., & Pedersen, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055632 · Cited by 35
Self-citationFibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
Cheung, B. M. Y., & Deng, H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.904745 · Cited by 35
Takahashi, A., Abe, K., Fujita, M., Hayashi, M., Okai, K., & Ohira, H. (2020) · Medicine · doi:10.1097/md.0000000000020399 · Cited by 32
Kim, W. J., Kim, S. S., Lee, H. C., Song, S. H., Bae, M. J., Yi, Y., Jeon, Y. K., Kim, B. H., Kim, Y. K., & Kim, I. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.5.586 · Cited by 34
Arias‐Calderón, M., Casas, M., Balanta‐Melo, J., Morales, C., Hernández, N., Llanos, P., Jaimovich, E., & Buvinic, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1059020 · Cited by 33
Legaard, G. E., & Pedersen, B. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814593-7.00013-x · Cited by 32
Self-citationJeon, J. Y., Choi, S., Ha, E. S., Kim, T. H., Jung, J. G., Han, S. J., Kim, H. J., Kim, D. J., KANG, Y. Y., & Lee, K. W. (2016) · Endocrine · doi:10.1007/s12020-015-0845-x · Cited by 31
Fjeldborg, K., Pedersen, S. B., Møller, H. J., & Richelsen, B. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.03.033 · Cited by 31
Pérez‐Martí, A., Sandoval, V., Marrero, P. F., Haro, D., & Relat, J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0034 · Cited by 30
Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease
Esteghamati, A., Khandan, A., Momeni, A., Behdadnia, A., Ghajar, A., Nikdad, M., Noshad, S., Nakhjavani, M., & Afarideh, M. (2017) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-017-1554-7 · Cited by 29
Strączkowski, M., Karczewska‐Kupczewska, M., Adamska, A., Otziomek, E., Kowalska, I., & Nikołajuk, A. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.10 · Cited by 28
Hanks, L. J., Casazza, K., Ashraf, A. P., Wallace, S. B., & Gutiérrez, O. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12552 · Cited by 27
Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini‐review
Yuan, D., Wu, B. J., Henry, A., Rye, K., & Ong, K. L. (2018) · Clinical Endocrinology · doi:10.1111/cen.13881 · Cited by 26
Exercise and Metabolic Health: The Emerging Roles of Novel Exerkines
Yazgan, B., Türkel, İ., Özerkliğ, B., ATAKAN, M. M., Aktitiz, S., & Koşar, Ş. N. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220629163524 · Cited by 25
Metabolic Effects of FGF-21: Thermoregulation and Beyond
Ni, B., Farrar, J. S., Vaitkus, J. A., & Celi, F. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00148 · Cited by 24
Fibroblast Growth Factor 21: A Fascinating Perspective on the Regulation of Muscle Metabolism
Li, S., Chen, J., Wei, P., Zou, T., & You, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316951 · Cited by 23
Zhou, S., Qian, B., Wang, L., Zhang, C., Hogan, M. V., & Li, H. (2018) · Muscle & Nerve · doi:10.1002/mus.26195 · Cited by 23
Oflazoğlu, U., Cağlar, S., Yılmaz, H. E., Önal, H. T., Varol, U., Salman, T., Yıldız, Y., Ünal, S., Güç, Z. G., Küçükzeybek, Y., et al. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00635-3 · Cited by 24
Wang, D., Xu, S., Ding, W., Zhu, C., Deng, S., Qiu, X., & Wang, Z. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12859 · Cited by 23
Myokines: Novel therapeutic targets for diabetic nephropathy
Yang, M., Luo, S., Yang, J., Chen, W., He, L., Liu, D., Zhao, L., & Wang, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1014581 · Cited by 22
Wang, Yu, Zhang, Floyd, Z. E., Lian, Cefalu, & Boudreau (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30887 · Cited by 22
Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
Guo, C. Y., Zhao, L., Li, Y., Deng, X., & Yuan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29879 · Cited by 22
Petri, I., Dumbell, R., Scherbarth, F., Steinlechner, S., & Barrett, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090253 · Cited by 22
Zibar, K., Blaslov, K., Bulum, T., Čuča, J. K., & Duvnjak, L. S. (2014) · Endocrine · doi:10.1007/s12020-014-0413-9 · Cited by 21
Vasyukova, O. V., Kasyanova, Y. V., Okorokov, P. L., & Bezlepkina, O. B. (2021) · Problems of Endocrinology · doi:10.14341/probl12779 · Cited by 20
Liu, X., Wang, Y., Zhao, S., & Li, X. (2017) · BioMed Research International · doi:10.1155/2017/1648715 · Cited by 20
Meier, R. P. H., Noguchi, H., Kelly, Y. M., Sarwal, M., Conti, G., Ward, C., Halleluyan, R., Tavakol, M., Stock, P. G., & Freise, C. E. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001053 · Cited by 20
Lee, J., Yoon, E., Jung, S. Y., Yim, K.-T., & Kim, D. (2021) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2142260.130 · Cited by 19
Influence of Klotho Protein Levels in Obesity and Sarcopenia: A Systematic Review
Cobo, D. A., Estébanez, B., Arnáiz, E. G., García-Pérez, M. P., Rivera-Viloria, M., de la Maza, B. P., Galindo, D. E. B., Sastre, D. G., Ballesteros-Pomar, M. D., & Cuevas, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051915 · Cited by 19
Metabolic characteristics and therapeutic potential of brown and ?beige? adipose tissues
Koksharova, E., Mayorov, A. Y., Shestakova, M. V., & Dedov, I. I. (2014) · Diabetes Mellitus · doi:10.14341/dm201445-15 · Cited by 19
Lombardi, G., Sansoni, V., & Banfi, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.11 · Cited by 17
Timofte, D. V., Tudor, R. C., Mocanu, V., & Labusca, L. S. (2024) · Nutrients · doi:10.3390/nu16234231 · Cited by 16
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms
Richter, M. M., Kemp, I. M., Heebøll, S., Winther‐Sørensen, M., Kjeldsen, S. A. S., Jensen, N. J., Nybing, J. D., Linden, F. H., Høgh‐Schmidt, E., Boesen, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155915 · Cited by 15
Self-citationThe effect of palmitate supplementation on gene expression profile in proliferating myoblasts
Grabiec, K., Majewska, A., Wicik, Z., Milewska, M., Błaszczyk, M., & Grzelkowska‐Kowalczyk, K. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9324-2 · Cited by 14
Lim, J. Y., & Kim, E. (2023) · Metabolites · doi:10.3390/metabo13090979 · Cited by 14
Wang, Y., Wang, R., Liu, Y., Bai, L., Liu, L., He, L., Deng, H. M., Li, T., Xu, S., Chen, L., et al. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-00940-7 · Cited by 14
Brandão, L. E. M., Espes, D., Westholm, J. O., Martikainen, T., Westerlund, N., Lampola, L., Popa, A., Vogel, H., Schürmann, A., Dickson, S. L., et al. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13472 · Cited by 15
Sarkopenia pada Lansia: Problem Diagnosis dan Tatalaksana
Sanglah, R., & Aryana, I. G. P. S. (2021) · Baswara Press eBooks · doi:10.53638/9786239795580 · Cited by 13
KLOTHO, FGF21 AND FGF23: NOVEL PATHWAYS TO MUSCULOSKELETAL HEALTH?
Bartali, B., Semba, R. D., & de Araújo, A. B. (2013) · The Journal of Frailty & Aging · doi:10.14283/jfa.2013.26 · Cited by 13
Skeletal Muscle as Endocrine Organ
Ma, M., Zhang, Z., Hai, B., & Zhang, Y. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_22 · Cited by 12
LPS infusion suppresses serum FGF21 levels in healthy adult volunteers
Lauritzen, E. S., Rittig, N. F., Bach, E., Møller, N., & Bjerre, M. (2017) · Endocrine Connections · doi:10.1530/ec-16-0103 · Cited by 12
Hui, Q., Huang, Z., Pang, S., Yang, X., Li, J., Yu, B., Tang, L., Li, X., & Wang, X. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9470-y · Cited by 12
Heidari, Z., & Hasanpour, M. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102296 · Cited by 11
Myokines and interorgan crosstalk: bridging exercise to health promotion and disease prevention
Ha, J., Sung, S., & Kim, H. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448218.109 · Cited by 10
Geidl, B., Hochuli, M., Spinas, G. A., & Gerber, P. A. (2022) · Nutrients · doi:10.3390/nu14194169 · Cited by 10
Wu, P., Wu, L., Wang, Y., Ye, Y., Yang, X., Yuan, J., Xu, J., Wang, Y., Song, X., Yan, S., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3717 · Cited by 9
Reinhard, M., Frystyk, J., Jespersen, B., Randers, E., Bibby, B. M., & Ivarsen, P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12737 · Cited by 9
Streeter, J., Persaud, L., Gao, J., Manika, D., Fairman, W., García-Peña, L. M., Marti, A., Manika, C., Gaddi, S., Schickling, B., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1325286 · Cited by 8
Markofski, M. M., Jennings, K., Dolan, C., Davies, N. A., LaVoy, E. C. P., Ryan, E. J., & Carrillo, A. E. (2019) · American Journal of Lifestyle Medicine · doi:10.1177/1559827619866157 · Cited by 8
Fangmann, D., Geisler, C., Schlicht, K., Hartmann, K., Köpke, J., Tiede, A., Settgast, U., Türk, K., Schulte, D. M., Altmann, K., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.006 · Cited by 8
Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases
Xie, T., & Leung, P. S. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000039 · Cited by 7
The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans
Richter, M. M., & Plomgaard, P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab121 · Cited by 7
The emerging role of fibroblast growth factor 21 in diabetic nephropathy
Mao, S., Ren, X., & Zhang, J. (2016) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147582 · Cited by 7
Pedersen, B. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_31 · Cited by 7
Self-citationRoles of myokines in osteoporosis under physiological and diabetic conditions
Ji, X., Hu, X., Xu, T., & Yang, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1600218 · Cited by 5
Potential role of Akt in the regulation of fibroblast growth factor 21 by berberine
Hirai, T., Wang, W., Murono, N., Iwasa, K., & Inoue, M. (2023) · Journal of Natural Medicines · doi:10.1007/s11418-023-01755-1 · Cited by 4
Ghiyami, S. H., Afroundeh, R., Pourvaghar, M. J., Sadeghi, A., & Katebi, L. (2023) · Complementary Medicine Journal · doi:10.61186/cmja.12.4.1 · Cited by 4
Effect of exercise on Fibroblast Growth Factor 21 levels in healthy males and females
Peterson, M. N., Richardson, K. A., & Funderburk, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321738 · Cited by 3
Felder, M., Maushart, C. I., Gashi, G., Senn, J. R., Becker, A. S., Müller, J., Baláž, M., Wolfrum, C., Burger, I. A., & Betz, M. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.765807 · Cited by 3
Stevanović, D., Hebert, A. J., Desai, B. N., Singhal, G., Adams, A. C., Flier, J. S., & Maratos–Flier, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.27.921361 · Cited by 3
Nutritional Risk of Candidates for Simultaneous Pancreatic–Kidney Transplantation—A Narrative Review
Mizerska, A., Durlik, M., & Kędzierska-Kapuza, K. (2023) · Nutrients · doi:10.3390/nu15194179 · Cited by 2
Current Strategies for the Biochemical Diagnosis and Monitoring of Mitochondrial Disease
Hargreaves, I. P. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-241-9 · Cited by 2
Fahrner, A., Laiferová, N. A., Ukropcová, B., Ukropec, J., & Krützfeldt, J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad041 · Cited by 2
Fibroblast growth factor 21: new insights from human studies
Hansen, J. S., & Plomgaard, P. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000084 · Cited by 2
Jak mięśnie komunikują się z innymi narządami i co z tego wynika?
Ziemann, E. (2021) · Kosmos · doi:10.36921/kos.2020_2707 · Cited by 2
Alieva, A. M., Baikova, I. E., Reznik, E. V., Valiev, R. K., Akhmatov, I. Z., Arakelyan, R. A., Saryev, M. N., & Nikitin, I. G. (2022) · Russian Medicine · doi:10.17816/medjrf108900 · Cited by 2
Song, J., Cho, E. Y., Kwon, Y. R., Park, J. S., Nam, J. S., & Kim, Y. (2026) · The Journal of Physiology · doi:10.1113/jp291172 · Cited by 1
Tong, F., Chen, Y., Gui, H., Li, A., Li, H., Pei, Y., Wu, Z., & Wang, M. (2026) · Metabolites · doi:10.3390/metabo16080562 · Cited by 1
Energy Metabolism in Skeletal Muscle and its Link to Insulin Resistance
Wang, M. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch6 · Cited by 1
Pedersen, B. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_31-1 · Cited by 1
Self-citationPathophysiology and Pharmacology of FGFs
Li, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816142-5.00004-7 · Cited by 1
Biomarkers of Insulin Resistance
Cox‐York, K. A., & Pereira, R. I. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_11 · Cited by 1
Mashili, F. L. (2012) · Figshare · Cited by 1
The role of FGF21 in regulating energy homeostasis
Ameka, M., Potthoff, M. J., Sigmund, C. D., Grobe, J. L., Domann, F. E., & Kwitek, A. E. (2017) · doi:10.17077/etd.vfkd2il1 · Cited by 1
Discovery and Characterization of Skeletal Muscle-Derived Myokines
Little, H. C. (2019) · Cited by 1
Lindegaard, B., Hvid, T., Grøndahl, T. S., Frøsig, C., Gerstoft, J., Højman, P., & Pedersen, B. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127249 · Cited by 1
Self-citationAcute inhibition of iron-sulfur cluster biosynthesis disrupts metabolic flexibility in micePreprint
Molenaars, M., Mir, H., Alvarez, S., Arivazhagan, L., Rosselot, C., Zhan, D., Park, C. Y., García-Ocaña, A., Schmidt, A. M., & Possemato, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.19.608291 · Cited by 1
Tomasch, J. (2022) · reposiTUm (TU Wien) · doi:10.34726/hss.2022.107420 · Cited by 1
Adipose Tissue and Skeletal Muscle Plasticity in Obesity and Metabolic Disease
Ukropec, J., & Ukropcov, B. (2012) · InTech eBooks · doi:10.5772/28506
Regulació de FGF21 en la cèl.lula muscular
Aulinas, F. R. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Organ-Specific Physiological Responses to Acute Physical Exercise and Long-Term Training
Garatachea, N., Berger, N. A., Lucía, A., Knuuti, J. M., HEINONEN, I. H. A., Kalliokoski, K. K., Hannukainen, J. C., Duncker, D. J., Nuutila, P., Bouchard, C., et al. (2015)
Skjølsvik, A. M. (2012) · NORA - Norwegian Open Research Archives
FGF-21 - O Novo Regulador Metabólico
Oliveira, I. S. P. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9xqj-y217
Parmar, B. (2017) · Nottingham ePrints (University of Nottingham)
Siemienowicz, K. J. (2018) · ERA
Farsani, Z. Y., Taghian, F., & Banitalebi, E. (2019) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2019.21
Lee, S. Y. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136835
Hepatic FGF21 is under the Regulation of the Canonical Wnt Signaling Pathway
Badakhshi, Y. (2020) · TSpace (University of Toronto)
Rezaei, M., Ghofrani, M., Batavani, M. R., & Emadi, S. (2021) · یافته · doi:10.32592/yafteh.2021.23.3.4
Metadata
- Authors
- Hojman, P., Pedersen, M., Nielsen, A. R., Krogh-Madsen, R., Yfanti, C., Åkerstrom, T., Nielsen, S., & Pedersen, B. K.
- Affiliations
- From the Department of Infectious Diseases, Centre of Inflammation and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
- University of Copenhagen (DK)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-08-31
- Volume
- 58
- Issue
- 12
- Pages
- 2797-2801
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2780875
- OpenAlex
- W2133997161
- Cited by
- 198
- References
- 19
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 6 · 2023: 12 · 2022: 9 · 2021: 13 · 2020: 11 · 2019: 14 · 2018: 10 · 2017: 12 · 2016: 19 · 2015: 19 · 2014: 14 · 2013: 15 · 2012: 15
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- Danmarks Grundforskningsfond
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- FGF21, skeletal muscle, hyperinsulinemia, insulin resistance, myokines, hyperinsulinemic-euglycemic clamp, HDL cholesterol, sex differences, glucose metabolism
- MeSH terms
- Acute Disease, Biopsy, Blood Glucose, Diabetes Mellitus, Type 2, Enzyme-Linked Immunosorbent Assay, Fasting, Female, Fibroblast Growth Factors, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Male, Linear Models, Polymerase Chain Reaction, Muscle, Skeletal, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.